ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma

Amino Acids

Volumn 40, Issue 3, 2011, Pages 1003-1013

  Kang, Yun Hee ^a   Ji, Na Young ^a   Lee, Chung Il ^a   Lee, Hee Gu ^a   Kim, Jae Wha ^a   Yeom, Young Il ^a   Kim, Dae Ghon ^b   Yoon, Seung Kew ^c   Kim, Jong Wan ^d   Park, Pil Je ^e   Song, Eun Young ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Chonbuk National University Medical School   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d Dankook University   (South Korea)

^e BioInfra Inc   (South Korea)

Author keywords

Cell cycle; Cell migration; Diagnostic marker; ESM 1; Hepatocellular carcinoma

Indexed keywords

ALPHA FETOPROTEIN; CYCLIN D1; ENDOTHELIAL CELL SPECIFIC MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEOGLYCAN; SMALL INTERFERING RNA; TUMOR MARKER; UNCLASSIFIED DRUG;

ACUTE HEPATITIS; AREA UNDER THE CURVE; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL INVASION; CELL MIGRATION; CELL SURVIVAL; CHRONIC HEPATITIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER PARENCHYMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING;

CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; GENE SILENCING; HUMANS; LIVER NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROTEOGLYCANS; RNA, SMALL INTERFERING;

EID: 79954440536     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-010-0729-6     Document Type: Article

References (29)

1. M Aitkenhead SJ Wang MN Nakatsu J Mestas C Heard CC Hughes 2002 Identification of endothelial cell genes expressed in an in vitro model of angiogenesis: induction of ESM-1, (beta)ig-h3, and NrCAM Microvasc Res 63 159 171 1:CAS:528:DC%2BD38XhsFSqu7k%3D 10.1006/mvre.2001.2380 11866539 (Pubitemid 34971632)
2. D Bechard V Meignin A Scherpereel S Oudin G Kervoaze P Bertheau A Janin A Tonnel P Lassalle 2000 Characterization of the secreted form of endothelial-cell-specific molecule 1 by specific monoclonal antibodies J Vasc Res 37 417 425 1:CAS:528:DC%2BD3cXnvVeqtbs%3D 10.1159/000025758 11025405
3. JG Filep 2006 Endocan or endothelial cell-specific molecule-1: a novel prognostic marker of sepsis? Crit Care Med 34 574 575 10.1097/01.CCM.0000199054. 13823.A7 16424758 (Pubitemid 43145655)
4. FB Furnari HJ Huang WK Cavenee 1998 The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells Cancer Res 58 5002 5008 1:CAS:528:DyaK1cXnsFSmsbg%3D 9823298 (Pubitemid 28521148)
5. AI Gomaa SA Khan MB Toledano I Waked SD Taylor-Robinson 2008 Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis World J Gastroenterol 14 4300 4308 10.3748/wjg.14.4300 18666317
6. BD Grigoriu F Depontieu A Scherpereel D Gourcerol P Devos T Ouatas JJ Lafitte MC Copin AB Tonnel P Lassalle 2006 Endocan expression and relationship with survival in human non-small cell lung cancer Clin Cancer Res 12 4575 4582 1:CAS:528:DC%2BD28XnvVGksrY%3D 10.1158/1078-0432.CCR-06-0185 16899604 (Pubitemid 44297807)
7. GW Huang YM Tao X Ding 2009 Endocan expression correlated with poor survival in human hepatocellular carcinoma Dig Dis Sci 54 389 394 1:CAS:528:DC%2BD1MXhtlOqtLo%3D 10.1007/s10620-008-0346-3 18592377
8. C Jimenez RA Portela M Mellado JM Rodriguez-Frade J Collard A Serrano AC Martinez J Avila AC Carrera 2000 Role of the PI3 K regulatory subunit in the control of actin organization and cell migration J Cell Biol 151 249 262 1:CAS:528:DC%2BD3cXnsVaqs7Y%3D 10.1083/jcb.151.2.249 11038173
9. P Lassalle S Molet A Janin JV Heyden J Tavernier W Fiers R Devos AB Tonnel 1996 ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines J Biol Chem 271 20458 20464 1:CAS:528:DyaK28Xlt1ygurk%3D 10.1074/jbc.271.34.20458 8702785 (Pubitemid 26281817)
10. DA Lauffenburger AF Horwitz 1996 Cell migration: a physically integrated molecular process Cell 84 359 369 1:CAS:528:DyaK28XhtFWqtr8%3D 10.1016/S0092-8674(00)81280-5 8608589 (Pubitemid 26058561)
11. DM Li H Sun 1998 PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells Proc Natl Acad Sci USA 95 15406 15411 1:CAS:528:DyaK1MXhvFaksw%3D%3D 10.1073/pnas.95.26.15406 9860981 (Pubitemid 29018711)
12. JB Lopez 2005 Recent developments in the first detection of hepatocellular carcinoma Clin Biochem Rev 26 65 79 16450014
13. JM Paramio M Navarro C Segrelles E Gomez-Casero JL Jorcano 1999 PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein Oncogene 18 7462 7468 1:CAS:528:DC%2BD3cXpslWk 10.1038/sj.onc.1203151 10602505 (Pubitemid 30035047)
14. L Perey J Benhattar R Peters P Jaunin S Leyvraz 2001 High tumour contamination of leukaphereses in patients with small cell carcinoma of the lung: a comparison of immunocytochemistry and RT-PCR Br J Cancer 85 1713 1721 1:CAS:528:DC%2BD38XnsVChtA%3D%3D 10.1054/bjoc.2001.2177 11742493 (Pubitemid 34081518)
15. S Persad AA Troussard TR McPhee DJ Mulholland S Dedhar 2001 Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation J Cell Biol 153 1161 1174 1:CAS:528:DC%2BD3MXktlOmsLY%3D 10.1083/jcb.153.6.1161 11402061 (Pubitemid 34289256)
16. A Radu V Neubauer T Akagi H Hanafusa MM Georgescu 2003 PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1 Mol Cell Biol 23 6139 6149 1:CAS:528:DC%2BD3sXms1Oht74%3D 10.1128/MCB.23.17.6139- 6149.2003 12917336 (Pubitemid 37013092)
17. K Reinhart M Meisner FM Brunkhorst 2006 Markers for sepsis diagnosis: what is useful? Crit Care Clin 22 503 519 1:CAS:528:DC%2BD2sXhtl2ns7jL 10.1016/j.ccc.2006.03.003 16893736 ix-x (Pubitemid 44163091)
18. E Rennel S Mellberg A Dimberg L Petersson J Botling A Ameur JO Westholm J Komorowski P Lassalle MJ Cross P Gerwins 2007 Endocan is a VEGF-A and PI3 K regulated gene with increased expression in human renal cancer Exp Cell Res 313 1285 1294 1:CAS:528:DC%2BD2sXjvFGrs74%3D 10.1016/j.yexcr.2007.01.021 17362927 (Pubitemid 46509777)
19. S Sarrazin E Adam M Lyon F Depontieu V Motte C Landolfi H Lortat-Jacob D Bechard P Lassalle M Delehedde 2006 Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy Biochim Biophys Acta 1765 25 37 1:CAS:528: DC%2BD2MXht12ku7%2FI 16168566 (Pubitemid 41752939)
20. A Scherpereel T Gentina B Grigoriu S Senechal A Janin A Tsicopoulos F Plenat D Bechard AB Tonnel P Lassalle 2003 Overexpression of endocan induces tumor formation Cancer Res 63 6084 6089 1:CAS:528:DC%2BD3sXnvVSitLg%3D 14522939 (Pubitemid 37187514)
21. A Scherpereel F Depontieu B Grigoriu B Cavestri A Tsicopoulos T Gentina M Jourdain J Pugin AB Tonnel P Lassalle 2006 Endocan, a new endothelial marker in human sepsis Crit Care Med 34 532 537 1:CAS:528:DC%2BD28Xls1GnsQ%3D%3D 10.1097/01.CCM.0000198525.82124.74 16424738 (Pubitemid 43145635)
22. CJ Sherr JM Roberts 1999 CDK inhibitors: positive and negative regulators of G1-phase progression Genes Dev 13 1501 1512 1:CAS:528:DyaK1MXktlOhsLs%3D 10.1101/gad.13.12.1501 10385618 (Pubitemid 29297917)
23. H Sun R Lesche DM Li J Liliental H Zhang J Gao N Gavrilova B Mueller X Liu H Wu 1999 PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway Proc Natl Acad Sci USA 96 6199 6204 1:CAS:528: DyaK1MXksFKksLw%3D 10.1073/pnas.96.11.6199 10339565 (Pubitemid 29256643)
24. LP Weng JL Brown C Eng 2001 PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model Hum Mol Genet 10 599 604 1:CAS:528:DC%2BD3MXit1ehtbg%3D 10.1093/hmg/10.6.599 11230179 (Pubitemid 32229364)
25. MF Yuen CL Lai 2005 Serological markers of liver cancer Best Pract Res Clin Gastroenterol 19 91 99 1:CAS:528:DC%2BD2MXitFCjtLs%3D 10.1016/j.bpg.2004. 10.003 15757806 (Pubitemid 40331499)
26. L Zhou J Liu F Luo 2006 Serum tumor markers for detection of hepatocellular carcinoma World J Gastroenterol 12 1175 1181 1:CAS:528: DC%2BD28XjvFelu7s%3D 16534867
27. X Zhu CH Kwon PW Schlosshauer LH Ellenson SJ Baker 2001 PTEN induces G(1) cell cycle arrest and decreases cyclin D3 levels in endometrial carcinoma cells Cancer Res 61 4569 4575 1:CAS:528:DC%2BD3MXktlWjsLs%3D 11389092 (Pubitemid 32685791)
28. AP Zou G Cheng YQ Pi WH Wang SB Yu DX Wang 1989 The role of lipoxygenase and cyclooxygenase metabolites in acute hypoxic pulmonary vasoconstriction in piglets J Tongji Med Univ 9 239 243 1:CAS:528:DyaK3cXktlygsbo%3D 10.1007/BF02909091 2517131
29. L Zuo SM Zhang RL Hu HQ Zhu Q Zhou SY Gui Q Wu Y Wang 2008 Correlation between expression and differentiation of endocan in colorectal cancer World J Gastroenterol 14 4562 4568 1:CAS:528:DC%2BD1cXhtlGgu7jE 10.3748/wjg.14.4562 18680240